92
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Analysis of Preferences in the Use of Fixed-Doses Combinations Antihypertensive Drugs in the Regions of Far-Eastern Federal District

ORCID Icon & ORCID Icon
Pages 265-272 | Published online: 27 May 2020

References

  • Federal State Statistics Service. Statistics. Official statistics. Population. Health care. Incidence. Incidence of socially significant diseases. Available from: https://gks.ru/folder/210/document/13218. Accessed May 5, 2020.
  • Chazova IE, Zhernakova YuV on behalf of the experts. Clinical guidelines. Diagnosis and treatment of arterial hypertension. Syst Hypertens. 2019;16(1):6–31. doi:10.26442/2075082X.2019.1.190179
  • Yusuf S, Lonn E, Pais P, et al.; HOPE-3 Investigators. Blood-pressure and cholesterol lowering in persons without cardiovascular disease. N Engl J Med. 2016;374(21):2032–2043. doi:10.1056/NEJMoa1600177.
  • Thomopoulos C, Parati G, Zanchetti A. Effects of blood-pressure-lowering treatment in hypertension: 9. Discontinuations for adverse events attributed to different classes of antihypertensive drugs: meta-analyses of randomized trials. J Hypertens. 2016;34(10):1921–1932. doi:10.1097/HJH.0000000000001052
  • Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a metaanalysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913. doi:10.1016/s0140-6736(02)11911-8
  • De Buyzere ML, Clement DL. Management of hypertension in peripheral arterial disease. Prog Cardiovasc Dis. 2008;50(4):238–63.41. doi:10.1016/j.pcad.2007.08.001
  • Corrao G, Zambon A, Parodi A, et al. Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy. J Hypertens. 2008;26(4):819–824. doi:10.1097/HJH.0b013e3282f4edd7
  • MacDonald TM, Williams B, Webb DJ, et al. British Hypertension Society Programme of Prevention And Treatment of Hypertension With Algorithm-based Therapy (PATHWAY). Combination therapy is superior to sequential monotherapy for the initial treatment of hypertension: a double-blind randomized controlled trial. J Am Heart Assoc. 2017;6(11):pii:e006986. doi:10.1161/JAHA.117.006986
  • Wald DS, Law M, Morris JK, et al. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med. 2009;122:290–300.68. doi:10.1016/j.amjmed.2008.09.038
  • Corrao G, Parodi A, Zambon A, et al. Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice. J Hypertens. 2010;28:1584–1590. doi:10.1097/HJH.0b013e328339f9fa
  • Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension. 2010;55(2):399–407. doi:10.1161/HYPERTENSIONAHA.109.139816
  • Mirzoyan A. Welcome to the chain. Pharm Messenger. 2016;11(840). Available from: https://pharmvestnik.ru/articles/dodro-pozhalovatj-v-set.html. Accessed May 5, 2020
  • Yakovleva NF. Sociological Research: Educational Manual. 2nd ed. Stern.M. FLINTA; 2014:25. Available from: http://www.kspu.ru/upload/documents/2015/10/19/9510fc4ecabf2052ab738becde976ef7/sotsiologicheskoe-issledovanie.pdf. Accessed May 5, 2020.
  • List of DDDs combined products. Available from: https://www.whocc.no/ddd/definition_and_general_considera/#ddds2. Accessed May 5, 2020.